From: Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing mice
Group | Dosage (g/kg) | Tumour weight (g) | Thymus weight (g) | Spleen weight (g) | Liver weight (g) | Body weight (g) |
---|---|---|---|---|---|---|
Control | 0 | 0.00 ± 0.00 | 0.10 ± 0.01 | 0.09 ± 0.01 | 1.21 ± 0.05 | 30.40 ± 1.44 |
Model | 0 | 0.60 ± 0.03 | 0.09 ± 0.02 | 0.12 ± 0.01 | 1.30 ± 0.07 | 32.57 ± 1.50 |
CY | 0.02 | 0.29 ± 0.01* | 0.07 ± 0.01 | 0.08 ± 0.01 | 1.15 ± 0.05 | 25.96 ± 1.32 |
ASMq low | 2 | 0.34 ± 0.02*# | 0.10 ± 0.01# | 0.11 ± 0.01*# | 1.35 ± 0.13*# | 27.34 ± 1.26*# |
ASMq medium | 4 | 0.21 ± 0.18*# | 0.09 ± 0.01*# | 0.12 ± 0.02*# | 1.35 ± 0.37 | 29.82 ± 2.24# |
ASMq high | 8 | 0.30 ± 0.53* | 0.11 ± 0.14# | 0.11 ± 0.11*# | 1.23 ± 1.30 | 30.22 ± 1.93# |